Relation of Covid-19 Vaccines with Inflammatory Neuropathies: Mini-Review
DOI:
https://doi.org/10.47363/JMHC/2022(4)195Keywords:
Neuropathies, Covid-19 Vaccines, InflammatoryAbstract
Numerous vaccines have been associated with various neurological adverse effects. Guillain-Barré syndrome [GBS], transverse myelitis, encephalitis, and optic neuritis have been reported following vaccination with human papillomavirus, yellow fever, measles, tetanus, rabies, rubella, and hepatitis A or B [1]. COVID-19 vaccines are not exempted from such adverse effects. Moderna (mRNA-1273), Pfizer-BioNTech (BNT162b2), and Johnson & Johnson’s Janssen (Ad26.COV 2.S) are the COVID-19 vaccines in use in the United States of America [USA]. These vaccines are generally well-tolerated. Common side effects are pain at injection site, fever, redness, headache, or myalgias. Neurological adverse events associated with COVID-19 vaccines are rare [2].